Nitroquinolone derivatives as nmda antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/16 (2006.01) A61K 31/47 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) C07D 215/22 (2006.01) C07D 401/00 (2006.01) C07D 405/00 (2006.01) C07D 409/00 (2006.01) C07D 413/02 (2006.01) C07D 413/06 (2006.01) C07D 417/02 (2006.01)

Patent

CA 2126076

2126076 9314067 PCTABS00024 A class of optionally 4-substituted 3-nitro-2-oxo-1,2,3,4-tetrathydroquinoline derivatives are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA receptor antagonist.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nitroquinolone derivatives as nmda antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nitroquinolone derivatives as nmda antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitroquinolone derivatives as nmda antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1679780

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.